⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19049167 | 0.74 | — | — | |
| SCHEMBL4206689 | 0.72 | — | — | |
| SCHEMBL10703920 | 0.67 | — | — | |
| SCHEMBL3441740 | 0.67 | — | — | |
| SCHEMBL17609533 | 0.67 | — | — | |
| SCHEMBL1268975 | 0.58 | — | — | |
| SCHEMBL3058723 | 0.56 | — | — | |
| Iodide SCHEMBL10728122 | 0.56 | — | — | |
| SCHEMBL11103519 | 0.56 | — | — | |
| SCHEMBL391309 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713666-A1 | MICROCAPSULES AND PROCESSES FOR THEIR PREPARATION | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2020-09-30 | — | — | EP | claimed |
| WO-2019102468-A1 | MICROCAPSULES AND PROCESSES FOR THEIR PREPARATION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-05-31 | — | — | WO | claimed |
| US-20160248099-A1 | OXYGEN REDUCTION CATALYSTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2016-08-25 | — | — | US | claimed |
| US-20140066629-A1 | PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-03-06 | — | — | US | claimed |
| EP-0110723-A1 | Method of preparing polyimide foams with blowing agents and products thereof | Imi-Tech Corporation (US) | 1984-06-13 | — | — | EP | claimed |
| JP-4178385-A | — | — | None | — | — | JP | disclosed |
| EP-4652160-A1 | COMPOUNDS FOR NUCLEIC ACID CLEAVAGE | Cambridge Enterprise Limited (GB) | 2025-11-26 | — | — | EP | disclosed |
| US-12478064-B2 | Microcapsules and processes for their preparation | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-11-25 | — | — | US | disclosed |
| US-20250059189-A1 | PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS | XENON PHARMACEUTICALS INC. (CA) | 2025-02-20 | — | — | US | disclosed |
| US-12054486-B2 | Pyridine derivatives and their use as sodium channel activators | XENON PHARMACEUTICALS INC. (CA) | 2024-08-06 | — | — | US | disclosed |
| WO-2024153950-A1 | COMPOUNDS FOR NUCLEIC ACID CLEAVAGE | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-07-25 | — | — | WO | disclosed |
| CN-118284602-A | Pyridine derivatives as sodium channel activators and uses thereof | 泽农医药公司 | 2024-07-02 | — | — | CN | disclosed |
| WO-2001032179-A1 | 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS | MERCK & CO., INC. (US) | 2001-05-10 | — | — | WO | disclosed |
| EP-0647137-A4 | GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF. | UNIV CALIFORNIA WEBER ECKARD (US) | 1998-09-16 | — | — | EP | disclosed |
| US-5622952-A | NERVOUS SYSTEM DISORDERS; ADMINISTERING 1,4-DIHYDROQUINOXALINE-2,3-DIONE | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) | 1997-04-22 | — | — | US | disclosed |
| US-5620979-A | TREATING NEURONAL LOSS ASSOCIATED WITH STROKE, ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA OR SURGERY | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) | 1997-04-15 | — | — | US | disclosed |
| US-5514680-A | ANTICONVULSANTS WITH 5,6,7-TRISUBSTITUTED-1,4-DIHYDROQUINOXALINE-2,3-DIONE | THE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY (US) | 1996-05-07 | — | — | US | disclosed |
| EP-0647137-A1 | GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994000124-A1 | GLYCINE RECEPTOR ANTAGONISTS AND THE USE THEREOF | WEBER ECKARD (US) | 1994-01-06 | — | — | WO | disclosed |
| JP-H04178385-A | DIKETOPYRIDOPYRAZINE DERIVATIVE | YAMANOUCHI PHARMACEUT CO LTD | 1992-06-25 | — | — | JP | disclosed |